Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

PSS JPEG
Analytical & Life Science Lab Equipment: Mass Spectrometry, HPLC, Chromatography, Bioreactors & More! Multiple Locations, US.

Starting: Sep 21st, 2026 7:00am PDT

Ending: Sep 22nd, 2026 9:00am PDT

Immediately Accepting Bids

Past Auctions

Late-Model Lab Equipment from Small Molecule Drug Discovery Co.: HPLCs, Imaging, PCR, Incubators, Cell Analysis & More! East Lyme, CT.

Starting: Sep 8th, 2025 8:00am EDT

Ending: Sep 9th, 2025 12:00pm EDT

Immediately Accepting Bids
State-of-the-Art Lab R&D Equipment: Mass Specs, HPLCs, GCMS Systems, Analyzers, Incubators & More! San Diego, CA.

Starting: Aug 12th, 2025 7:00am PDT

Ending: Aug 13th, 2025 9:00am PDT

Immediately Accepting Bids
Surplus Lab & Process Equipment from a Plant-Based Meat Innovator: Bioreactors, UHPLCs, Mass Spec, ICP-OES & More! Alameda, CA.

Starting: Aug 20th, 2025 7:00am PDT

Ending: Aug 21st, 2025 12:00pm PDT

Immediately Accepting Bids
Late-Model Lab Equipment: Cell Sorters, Imaging Microscopes, Centrifuges, Cold Storage, Incubators & More! Baltimore, MD.

Starting: Jul 29th, 2025 7:00am EDT

Ending: Jul 30th, 2025 12:00pm EDT

Immediately Accepting Bids
Sale #148: Biotech & Pharma Lab Equipment from Premier Manufacturer: HPLCs, Mass Specs, Centrifuges, Freezers & More! Locations, US.

Starting: Aug 19th, 2025 7:00am EDT

Ending: Aug 20th, 2025 12:00pm EDT

Immediately Accepting Bids
Sale #3: Massive Offering of Quality Lab and Process Equipment from CIAN Diagnostics! Hagerstown, MD.

Starting: Aug 25th, 2025 7:00am EDT

Ending: Aug 26th, 2025 10:00am EDT

Immediately Accepting Bids
Surplus Lab Equipment from Leading Natural Gas Producer: XRD Systems, GCs, HPLCs, ICP-OES, SEM, FT-IR & More! Oklahoma City, OK.

Starting: Jul 21st, 2025 7:00am CDT

Ending: Jul 22nd, 2025 10:00am CDT

Immediately Accepting Bids
Late-Model Lab Equipment from Biomedical Developer: Particle Analyzer, Acoustic Mixer, Rheometer, Freezers & More! Woburn, MA.

Starting: Jul 15th, 2025 7:00am EDT

Ending: Jul 16th, 2025 12:00pm EDT

Immediately Accepting Bids
Surplus BioPharma Lab Equipment from Unity Biotechnology: Microscopes, Cell Sorters, Centrifuges, XRD, PCRs & More! Hayward, CA.

Starting: Jul 10th, 2025 7:00am PDT

Ending: Jul 11th, 2025 9:00am PDT

Immediately Accepting Bids
Surplus Biopharma Equipment from Baylor College of Medicine: Illumina Sequencers, PCRs, Centrifuges & More! Hayward, CA.

Starting: Jul 24th, 2025 7:00am PDT

Ending: Jul 25th, 2025 9:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.